Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$716.44M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.38 | 3.92%
Avg Daily Range (30 D):	$0.32 | 3.05%
Avg Daily Range (90 D):	$0.37 | 3.56%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	.56M
Avg Daily Volume (90 D):	.94M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	764
Avg Institutional Trade:	$1.5M
Avg Institutional Trade (30 D):	$1M
Avg Institutional Trade (90 D):	$1.17M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$.97M
Avg Closing Trade (90 D):	$1.38M
Avg Closing Volume:	173.25K

News

Dec 12, 2025 @ 2:00 PM Firmware Signing Platform Market Size to Reach USD... Source: Sns Insider

Dec 10, 2025 @ 12:48 PM Fulcrum Therapeutics Announces Pricing of Upsized ... Source: Globe Newswire

Dec 6, 2025 @ 10:30 PM Fulcrum Therapeutics Announces Positive Initial Re... Source: Fulcrum Therapeutics

Nov 19, 2025 @ 1:00 PM Datanomix and Fulcrum Modernize Manufacturing Tech... Source: Greg Mchale And Sunny Han

Oct 10, 2025 @ 8:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: Kevin Gardner

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-1.18	$-.28	$-.28
Diluted EPS	$-1.18	$-.28	$-.28
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-73.22M	$-17.3M	$-17.66M
Operating Income / Loss	$-84.77M	$-19.82M	$-20.4M
Cost of Revenue
Net Cash Flow	$-44.13M	$-15.62M	$M
PE Ratio